Enhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16O/18O labeling and integrated two-dimensional LC-ESI-MALDI tandem MS

Molecular and Cellular Proteomics

Volumn 8, Issue 7, 2009, Pages 1453-1474

  Chi, Lang Ming ^a,b   Lee, Chien Wei ^a   Chang, Kai Ping ^b   Hao, Sheng Po ^b   Lee, Hang Mao ^a   Liang, Ying ^a   Hsueh, Chuen ^a,b   Yu, Chia Jung ^a   Lee, I Neng ^a   Chang, Yin Ju ^a   Lee, Shih Ying ^a   Yeh, Yuan Ming ^a   Chang, Yu Sun ^a   Chien, Kun Yi ^a   Yu, Jau Song ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; BIOLOGICAL MARKER; PROTEOME; UBIQUITIN;

ADULT; ARTICLE; CANCER CELL; CANCER TISSUE; CASE REPORT; CELL MOTILITY; COMPUTER SYSTEM; CONTROLLED STUDY; CROSS REACTION; DOWN REGULATION; ELECTROSPRAY MASS SPECTROMETRY; EPITHELIUM CELL; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LARYNX CANCER; LIQUID CHROMATOGRAPHY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICRODISSECTION; MOUTH CARCINOMA; ORAL SQUAMOUS CELL CARCINOMA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TANDEM MASS SPECTROMETRY; TONGUE CANCER; TUMOR CELL; UPREGULATION; WESTERN BLOTTING;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CHROMATOGRAPHY, LIQUID; DATABASES, PROTEIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERONS; MALE; MICRODISSECTION; MOLECULAR SEQUENCE DATA; MOUTH NEOPLASMS; NEOPLASM PROTEINS; OXYGEN ISOTOPES; PROTEOME; SIGNAL TRANSDUCTION; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 71049168341     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M800460-MCP200     Document Type: Article

References (142)

1. Scully, C., and Bagan, J. V. (2007) Recent advances in Oral Oncology. Oral Oncol. 43, 107-115
2. Funk, G. F., Karnell, L. H., Robinson, R. A., Zhen, W. K., Trask, D. K., and Hoffman, H. T. (2002) Presentation, treatment, and outcome of oral cavity cancer a National Cancer Data Base report. Head Neck 24, 165-180
3. Koch, B. B., Karnell, L. H., Hoffman, H. T., Apostolakis, L. W., Robinson, R. A., Zhen, W., and Menck, H. R. (2000) National cancer database report on chondrosarcoma of the head and neck. Head Neck 22, 408-425 (Pubitemid 30413308)
4. Zhen, W., Karnell, L. H., Hoffman, H. T., Funk, G. F., Buatti, J. M., and Menck, H. R. (2004) The National Cancer Data Base report on squamous cell carcinoma of the base of tongue. Head Neck 26, 660-674 (Pubitemid 39014630)
5. Jensen, L. H., Osterlind, K., and Rytter, C. (2008) Randomized cross-over study of patient preference for oral or intravenous vinorelbine in combination with carboplatin in the treatment of advanced NSCLC. Lung Cancer 62, 85-91
6. Liao, C. T., Chang, J. T., Wang, H. M., Ng, S. H., Hsueh, C., Lee, L. Y., Lin, C. H., Chen, I. H., Huang, S. F., Cheng, A. J., and Yen, T. C. (2008) Analysis of risk factors of predictive local tumor control in oral cavity cancer. Ann. Surg. Oncol. 15, 915-922
7. Tsantoulis, P. K., Kastrinakis, N. G., Tourvas, A. D., Laskaris, G., and Gorgoulis, V. G. (2007) Advances in the biology of oral cancer. Oral Oncol. 43, 523-534
8. Diaz, E. M., Jr., Holsinger, F. C., Zuniga, E. R., Roberts, D. B., and Sorensen, D. M. (2003) Squamous cell carcinoma of the buccal mucosa: one institution's experience with 119 previously untreated patients. Head Neck 25, 267-273
9. Alevizos, I., Mahadevappa, M., Zhang, X., Ohyama, H., Kohno, Y., Posner, M., Gallagher, G. T., Varvares, M., Cohen, D., Kim, D., Kent, R., Donoff, R. B., Todd, R., Yung, C. M., Warrington, J. A., and Wong, D. T. (2001) Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene 20, 6196-6204 (Pubitemid 32964432)
10. Ye, H., Yu, T., Temam, S., Ziober, B. L., Wang, J., Schwartz, J. L., Mao, L., Wong, D. T., and Zhou, X. (2008) Transcriptomic dissection of tongue squamous cell carcinoma. BMC Genomics 9, 69 (Pubitemid 351330970)
11. de Moraes, R. V., Oliveira, D. T., Landman, G., de Carvalho, F., Caballero, O., Nonogaki, S., Nishimoto, I., and Kowalski, L. P. (2008) E-cadherin abnormalities resulting from CPG methylation promoter in metastatic and nonmetastatic oral cancer. Head Neck 30, 85-92 (Pubitemid 351158325)
12. Wong, D. T. (2006) Salivary diagnostics powered by nanotechnologies, proteomics and genomics. J. Am. Dent. Assoc. 137, 313-321
13. Cheng, A. J., Chen, L. C., Chien, K. Y., Chen, Y. J., Chang, J. T., Wang, H. M., Liao, C. T., and Chen, I. H. (2005) Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology. Clin. Chem. 51, 2236-2244
14. Xie, H., Onsongo, G., Popko, J., de Jong, E. P., Cao, J., Carlis, J. V., Griffin, R. J., Rhodus, N. L., and Griffin, T. J. (2008) Proteomics analysis of cells in whole saliva from oral cancer patients via value-added three-dimensional peptide fractionation and tandem mass spectrometry. Mol. Cell. Proteomics 7, 486-498
15. Patel, V., Hood, B. L., Molinolo, A. A., Lee, N. H., Conrads, T. P., Braisted, J. C., Krizman, D. B., Veenstra, T. D., and Gutkind, J. S. (2008) Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression. Clin. Cancer Res. 14, 1002-1014
16. Ralhan, R., Desouza, L. V., Matta, A., Chandra Tripathi, S., Ghanny, S., Datta Gupta, S., Bahadur, S., and Siu, K. W. (2008) Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry. Mol. Cell. Proteomics 7, 1162-1173
17. Baker, H., Patel, V., Molinolo, A. A., Shillitoe, E. J., Ensley, J. F., Yoo, G. H., Meneses-García, A., Myers, J. N., El-Naggar, A. K., Gutkind, J. S., and Hancock, W. S. (2005) Proteome-wide analysis of head and neck squamous cell carcinomas using laser-capture microdissection and tandem mass spectrometry. Oral Oncol. 41, 183-199 (Pubitemid 40202885)
18. Wang, Z., Jiang, L., Huang, C., Li, Z., Chen, L., Gou, L., Chen, P., Tong, A., Tang, M., Gao, F., Shen, J., Zhang, Y., Bai, J., Zhou, M., Miao, D., and Chen, Q. (2008) Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma. Mol. Cell. Proteomics 7, 1639-1650
19. Staab, C. A., Ceder, R., Jägerbrink, T., Nilsson, J. A., Roberg, K., Jörnvall, H., Höög, J. O., and Grafström, R. C. (2007) Bioinformatics processing of protein and transcript profiles of normal and transformed cell lines indicates functional impairment of transcriptional regulators in buccal carcinoma. J. Proteome Res. 6, 3705-3717 (Pubitemid 47522759)
20. Mlynarek, A. M., Balys, R. L., Su, J., Hier, M. P., Black, M. J., and Alaoui-Jamali, M. A. (2007) A cell proteomic approach for the detection of secretable biomarkers of invasiveness in oral squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg. 133, 910-918
21. Weng, L. P., Wu, C. C., Hsu, B. L., Chi, L. M., Liang, Y., Tseng, C. P., Hsieh, L. L., and Yu, J. S. (2008) Secretome-based identification of Mac-2 binding protein as a potential oral cancer marker involved in cell growth and motility. J. Proteome Res. 7, 3765-3775
22. Ye, H., Wang, A., Lee, B. S., Yu, T., Sheng, S., Peng, T., Hu, S., Crowe, D. L., and Zhou, X. (2008) Proteomic based identification of manganese superoxide dismutase 2 (SOD2) as a metastasis marker for oral squamous cell carcinoma. Cancer Genomics Proteomics 5, 85-94 (Pubitemid 351642608)
23. Liu, T., Qian, W. J., Mottaz, H. M., Gritsenko, M. A., Norbeck, A. D., Moore, R. J., Purvine, S. O., Camp, D. G., 2nd, and Smith, R. D. (2006) Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry. Mol. Cell. Proteomics 5, 2167-2174
24. Issaq, H. J., Xiao, Z., and Veenstra, T. D. (2007) Serum and plasma proteomics. Chem. Rev. 107, 3601-3620
25. Zhang, H., Liu, A. Y., Loriaux, P., Wollscheid, B., Zhou, Y., Watts, J. D., and Aebersold, R. (2007) Mass spectrometric detection of tissue proteins in plasma. Mol. Cell. Proteomics 6, 64-71
26. Zang, L., Palmer Toy, D., Hancock, W. S., Sgroi, D. C., and Karger, B. L. (2004) Proteomic analysis of ductal carcinoma of the breast using laser capture microdissection, LC-MS, and 160/180 isotopic labeling. J. Proteome Res. 3, 604-612
27. Hood, B. L., Darfler, M. M., Guiel, T. G., Furusato, B., Lucas, D. A., Ringeisen, B. R., Sesterhenn, I. A., Conrads, T. P., Veenstra, T. D., and Krizman, D. B. (2005) Proteomic analysis of formalin-fixed prostate cancer tissue. Mol. Cell. Proteomics 4, 1741-1753
28. Craven, R. A., and Banks, R. E. (2001) Laser capture microdissection and proteomics: possibilities and limitation. Proteomics 1, 1200-1204 (Pubitemid 33587876)
29. Melle, C., Ernst, G., Schimmel, B., Bleul, A., Koscielny, S., Wiesner, A., Bogumil, R., Moller, U., Osterloh, D., Halbhuber, K. J., and von Eggeling, F. (2003) Biomarker discovery and identification in laser microdissected head and neck squamous cell carcinoma with ProteinChip technology, two-dimensional gel electrophoresis, tandem mass spectrometry, and immunohistochemistry. Mol. Cell. Proteomics 2, 443-452
30. von Eggeling, F., Davies, H., Lomas, L., Fiedler, W., Junker, K., Claussen, U., and Ernst, G. (2000) Tissue-specific microdissection coupled with ProteinChip array technologies: applications in cancer research. BioTechniques 29, 1066-1070
31. Melle, C., Ernst, G., Schimmel, B., Bleul, A., Koscielny, S., Wiesner, A., Bogumil, R., Möller, U., Osterloh, D., Halbhuber, K. J., and von Eggeling, F. (2004) A technical triade for proteomic identification and characterization of cancer biomarkers. Cancer Res. 64, 4099-4104 (Pubitemid 38802410)
32. Unwin, R. D., Pierce, A., Watson, R. B., Sternberg, D. W., and Whetton, A. D. (2005) Quantitative proteomic analysis using isobaric protein tags enables rapid comparison of changes in transcript and protein levels in transformed cells. Mol. Cell. Proteomics 4, 924-935
33. Shiio, Y., and Aebersold, R. (2006) Quantitative proteome analysis using isotope-coded affinity tags and mass spectrometry. Nat. Protoc. 1, 139-145
34. Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B., Steen, H., Pandey, A., and Mann, M. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 1, 376-386
35. Ong, S. E., and Mann, M. (2006) A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC). Nat. Protoc. 1, 2650-2660
36. 18O-labeling strategies for quantitative proteomics. Mass Spectrom. Rev. 26, 121-136
37. 18O labeling: a tool for proteomics. Rapid Commun. Mass Spectrom. 15, 2456-2465
38. Hajkova, D., Rao, K. C., and Miyagi, M. (2006) pH dependency of the carboxyl oxygen exchange reaction catalyzed by lysyl endopeptidase and trypsin. J. Proteome Res. 5, 1667-1673 (Pubitemid 44036140)
39. Matta, A., DeSouza, L. V., Shukla, N. K., Gupta, S. D., Ralhan, R., and Siu, K. W. (2008) Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry. J. Proteome Res. 7, 2078-2087
40. Sudha, R., Kawachi, N., Du, P., Nieves, E., Belbin, T. J., Negassa, A., Angeletti, R. H., and Prystowsky, M. B. (2007) Global proteomic analysis distinguishes biologic differences in head and neck squamous carcinoma. Lab. Investig. 87, 755-766
41. Lin, S. C., Liu, C. J., Chiu, C. P., Chang, S. M., Lu, S. Y., and Chen, Y. J. (2004) Establishment of OC3 oral carcinoma cell line and identification of NF-kappaB activation responses to areca nut extract. J. Oral Pathol. Med. 33, 79-86
42. Yang, C. Y., and Meng, C. L. (1994) Regulation of PG synthase by EGF and PDGF in human oral, breast, stomach, and fibrosarcoma cancer cell lines. J. Dent. Res. 73, 1404-1415
43. Wu, C. C., Chen, H. C., Chen, S. J., Liu, H. P., Hsieh, Y. Y., Yu, C. J., Tang, R., Hsieh, L. L., Yu, J. S., and Chang, Y. S. (2008) Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes. Proteomics 8, 316-332 (Pubitemid 351212330)
44. Wu, C. C., Chien, K. Y., Tsang, N. M., Chang, K. P., Hao, S. P., Tsao, C. H., Chang, Y. S., and Yu, J. S. (2005) Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model. Proteomics 5, 3173-3182
45. Chien, K. Y., Chang, Y. S., Yu, J. S., Fan, L. W., Lee, C. W., and Chi, L. M. (2006) Identification of a new in vivo phosphorylation site in the cytoplasmic carboxyl terminus of EBV-LMP1 by tandem mass spectrometry. Biochem. Biophys. Res. Commun. 348, 47-55
46. Tse, K. P., Tsang, N. M., Chen, K. D., Li, H. P., Liang, Y., Hsueh, C., Chang, K. P., Yu, J. S., Hao, S. P., Hsieh, L. L., and Chang, Y. S. (2007) MCP-1 promoter polymorphism at 2518 is associated with metastasis of nasopharyngeal carcinoma after treatment. Clin. Cancer Res. 13, 6320-6326
47. Yu, J. S., Chen, W. J., Ni, M. H., Chan, W. H., and Yang, S. D. (1998) Identification of the regulatory autophosphorylation site of autophosphorylation-dependent protein kinase (auto-kinase). Evidence that auto-kinase belongs to a member of the p21-activated kinase family. Biochem. J. 334, 121-131
48. Yang, Y., Zhang, S., Howe, K., Wilson, D. B., Moser, F., Irwin, D., and Thannhauser, T. W. (2007) A comparison of nLC-ESI-MS/MS and nLC-MALDI-MS/MS for GeLC-based protein identification and iTRAQ-based shotgun quantitative proteomics. J. Biomol. Tech. 18, 226-237
49. Hattan, S. J., and Parker, K. C. (2006) Methodology utilizing MS signal intensity and LC retention time for quantitative analysis and precursor ion selection in proteomic LC-MALDI analyses. Anal. Chem. 78, 7986-7996
50. Chen, H. S., Rejtar, T., Andreev, V., Moskovets, E., and Karger, B. L. (2005) Enhanced characterization of complex proteomic samples using LC-MALDI MS/MS: exclusion of redundant peptides from MS/MS analysis in replicate runs. Anal. Chem. 77, 7816-7825
51. 18O labeling for relative quantification of differential protein complex composition. Rapid Commun. Mass Spectrom. 18, 869-876
52. 18O exchange for comparative proteomics: tandem mass spectrometry comparison using MALDI-TOF, ESI-QTOF, and ESI-ion trap mass spectrometers. J. Am. Soc. Mass Spectrom. 14, 704-718
53. Nikolsky, Y., Ekins, S., Nikolskaya, T., and Bugrim, A. (2005) A novel method for generation of signature networks as biomarkers from complex high throughput data. Toxicol. Lett. 158, 20-29
54. Rakkola, R., Matikainen, S., and Nyman, T. A. (2005) Proteome characterization of human NK-92 cells identifies novel IFN-alpha and IL-15 target genes. J. Proteome Res. 4, 75-82 (Pubitemid 40344459)
55. Der, S. D., Zhou, A., Williams, B. R., and Silverman, R. H. (1998) Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. U. S. A. 95, 15623-15628
56. Yao, Y., Kubota, T., Sato, K., Takeuchi, H., Kitai, R., and Matsukawa, S. (2005) Interferons upregulate thymidine phosphorylase expression via JAK-STAT-dependent transcriptional activation and mRNA stabilization in human glioblastoma cells. J. Neurooncol. 72, 217-223 (Pubitemid 40867403)
57. Andersen, J. B., and Hassel, B. A. (2006) The interferon regulated ubiquitin-like protein, ISG15, in tumorigenesis: friend or foe? Cytokine Growth Factor Rev. 17, 411-421
58. Pitha-Rowe, I. F., and Pitha, P. M. (2007) Viral defense, carcinogenesis and ISG15: novel roles for an old ISG. Cytokine Growth Factor Rev. 18, 409-417
59. Zhao, C., Denison, C., Huibregtse, J. M., Gygi, S., and Krug, R. M. (2005) Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc. Natl. Acad. Sci. U. S. A. 102, 10200-10205
60. Giannakopoulos, N. V., Luo, J. K., Papov, V., Zou, W., Lenschow, D. J., Jacobs, B. S., Borden, E. C., Li, J., Virgin, H. W., and Zhang, D. E. (2005) Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. Biochem. Biophys. Res. Commun. 336, 496-506
61. Cowherd, S. M., Espina, V. A., Petricoin, E. F., 3rd, and Liotta, L. A. (2004) Proteomic analysis of human breast cancer tissue with laser-capture microdissection and reverse-phase protein microarrays. Clin. Breast Cancer 5, 385-392
62. Sanders, M. E., Dias, E. C., Xu, B. J., Mobley, J. A., Billheimer, D., Roder, H., Grigorieva, J., Dowsett, M., Arteaga, C. L., and Caprioli, R. M. (2008) Differentiating proteomic biomarkers in breast cancer by laser capture microdissection and MALDI MS. J. Proteome Res. 7, 1500-1507
63. Gu, Y., Wu, S. L., Meyer, J. L., Hancock, W. S., Burg, L. J., Linder, J., Hanlon, D. W., and Karger, B. L. (2007) Proteomic analysis of high-grade dysplastic cervical cells obtained from ThinPrep slides using laser capture microdissection and mass spectrometry. J. Proteome Res. 6, 4256-4268 (Pubitemid 350158503)
64. Lu, Q., Murugesan, N., Macdonald, J. A., Wu, S. L., Pachter, J. S., and Hancock, W. S. (2008) Analysis of mouse brain microvascular endothelium using immuno-laser capture microdissection coupled to a hybrid linear ion trap with Fourier transform-mass spectrometry proteomics platform. Electrophoresis 29, 2689-2695 (Pubitemid 351911896)
65. Liao, C. T., Huang, S. F., Chen, I. H., Chang, J. T., Wang, H. M., Ng, S. H., Hsueh, C., Lee, L. Y., Lin, C. H., Cheng, A. J., and Yen, T. C. (2009) Risk stratification of patients with oral cavity squamous cell carcinoma and contralateral neck recurrence following radical surgery. Ann. Surg. Oncol. 16, 159-170
66. Lo, W. L., Kao, S. Y., Chi, L. Y., Wong, Y. K., and Chang, R. C. (2003) Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: factors affecting survival. J. Oral Maxillofac. Surg. 61, 751-758
67. Paladini, R. D., Takahashi, K., Bravo, N. S., and Coulombe, P. A. (1996) Onset of re-epithelialization after skin injury correlates with a reorganization of keratin filaments in wound edge keratinocytes: defining a potential role for keratin 16. J. Cell Biol. 132, 381-397 (Pubitemid 26052572)
68. DePianto, D., and Coulombe, P. A. (2004) Intermediate filaments and tissue repair. Exp. Cell Res. 301, 68-76
69. Crowe, D. L., Milo, G. E., and Shuler, C. F. (1999) Keratin 19 downregulation by oral squamous cell carcinoma lines increases invasive potential. J. Dent. Res. 78, 1256-1263
70. Toruner, G. A., Ulger, C., Alkan, M., Galante, A. T., Rinaggio, J., Wilk, R., Tian, B., Soteropoulos, P., Hameed, M. R., Schwalb, M. N., and Dermody, J. J. (2004) Association between gene expression profile and tumor invasion in oral squamous cell carcinoma. Cancer Genet. Cytogenet. 154, 27-35
71. Stark, G. R. (2007) How cells respond to interferons revisited: from early history to current complexity. Cytokine Growth Factor Rev. 18, 419-423
72. Pfeffer, L. M., Dinarello, C. A., Herberman, R. B., Williams, B. R., Borden, E. C., Bordens, R., Walter, M. R., Nagabhushan, T. L., Trotta, P. P., and Pestka, S. (1998) Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. Cancer Res. 58, 2489-2499 (Pubitemid 28275413)
73. Takaoka, A., and Yanai, H. (2006) Interferon signalling network in innate defence. Cell Microbiol. 8, 907-922 (Pubitemid 43670834)
74. Kayagaki, N., Yamaguchi, N., Nakayama, M., Eto, H., Okumura, K., and Yagita, H. (1999) Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs. J. Exp. Med. 189, 1451-1460
75. Choi, E. A., Lei, H., Maron, D. J., Wilson, J. M., Barsoum, J., Fraker, D. L., El-Deiry, W. S., and Spitz, F. R. (2003) Stat1-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand and the cell-surface death signaling pathway by interferon beta in human cancer cells. Cancer Res. 63, 5299-5307 (Pubitemid 37139844)
76. Yang, C. H., Murti, A., Pfeffer, S. R., Kim, J. G., Donner, D. B., and Pfeffer, L. M. (2001) Interferon alpha/beta promotes cell survival by activating nuclear factor kappaB through phosphatidylinositol 3-kinase and Akt. J. Biol. Chem. 276, 13756-13761
77. Yang, C. H., Murti, A., and Pfeffer, L. M. (1998) STAT3 complements defects in an interferon-resistant cell line: evidence for an essential role for STAT3 in interferon signaling and biological activities. Proc. Natl. Acad. Sci. U. S. A. 95, 5568-5572
78. Lei, H., Furlong, P. J., Ra, J. H., Mullins, D., Cantor, R., Fraker, D. L., and Spitz, F. R. (2005) AKT activation and response to interferon-beta in human cancer cells. Cancer Biol. Ther. 4, 709-715
79. Fukushima, M., Okabe, H., Takechi, T., Ichikawa, W., and Hirayama, R. (2002) Induction of thymidine phosphorylase by interferon and taxanes occurs only in human cancer cells with low thymidine phosphorylase activity. Cancer Lett. 187, 103-110 (Pubitemid 35279338)
80. Takebayashi, Y., Yamada, K., Ohmoto, Y., Sameshima, T., Miyadera, K., Yamada, Y., Akiyama, S., and Aikou, T. (1995) The correlation of thymidine phosphorylase activity with the expression of interleukin 1 alpha, interferon alpha and interferon gamma in human colorectal carcinoma. Cancer Lett. 95, 57-62
81. Méndez, E., Fan, W., Choi, P., Agoff, S. N., Whipple, M., Farwell, D. G., Futran, N. D., Weymuller, E. A., Jr., Zhao, L. P., and Chen, C. (2007) Tumor-specific genetic expression profile of metastatic oral squamous cell carcinoma. Head Neck 29, 803-814 (Pubitemid 350303667)
82. Andersen, J. B., Aaboe, M., Borden, E. C., Goloubeva, O. G., Hassel, B. A., and Orntoft, T. F. (2006) Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer. Br. J. Cancer 94, 1465-1471 (Pubitemid 43772282)
83. Desai, S. D., Haas, A. L., Wood, L. M., Tsai, Y. C., Pestka, S., Rubin, E. H., Saleem, A., Nur-E-Kamal, A., and Liu, L. F. (2006) Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway. Cancer Res. 66, 921-928 (Pubitemid 43165959)
84. Desai, S. D., Wood, L. M., Tsai, Y. C., Hsieh, T. S., Marks, J. R., Scott, G. L., Giovanella, B. C., and Uu, L. F. (2008) ISG15 as a novel tumor biomarker for drug sensitivity. Mol. Cancer Ther. 7, 1430-1439
85. Desai, S. D., Mao, Y., Sun, M., Li, T. K., Wu, J., and Liu, L. F. (2000) Ubiquitin, SUMO-1, and UCRP in camptothecin sensitivity and resistance. Ann. N.Y. Acad. Sci. 922, 306-308
86. Ma, C., Rong, Y., Radiloff, D. R., Datto, M. B., Centeno, B., Bao, S., Cheng, A. W., Lin, F., Jiang, S., Yeatman, T. J., and Wang, X. F. (2008) Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. Genes Dev. 22, 308-321 (Pubitemid 351214273)
87. Buckhaults, P., Rago, C., St Croix, B., Romans, K. E., Saha, S., Zhang, L., Vogelstein, B., and Kinzler, K. W. (2001) Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Res. 61, 6996-7001 (Pubitemid 32946484)
88. Schneider, D., Kleeff, J., Berberat, P. O., Zhu, Z., Korc, M., Friess, H., and Büchler, M. W. (2002) Induction and expression of betaig-h3 in pancreatic cancer cells. Biochim. Biophys. Acta 1588, 1-6
89. Lee, T. K., Poon, R. T., Man, K., Guan, X. Y., Ma, S., Liu, X. B., Myers, J. N., and Yuen, A. P. (2007) Fascin over-expression is associated with aggressiveness of oral squamous cell carcinoma. Cancer Lett. 254, 308-315 (Pubitemid 47135617)
90. Chen, S. F., Yang, S. F., Li, J. W., Nieh, P. C., Lin, S. Y., Fu, E., Bai, C. Y., Jin, J. S., Lin, C. Y., and Nieh, S. (2007) Expression of fascin in oral and oropharyngeal squamous cell carcinomas has prognostic significance: a tissue microarray study of 129 cases. Histopathology 51, 173-183 (Pubitemid 47083998)
91. Hashimoto, Y., Ito, T., Inoue, H., Okumura, T., Tanaka, E., Tsunoda, S., Higashiyama, M., Watanabe, G., Imamura, M., and Shimada, Y. (2005) Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma. Clin. Cancer Res. 11, 2597-2605
92. Zhang, H., Xu, L., Xiao, D., Xie, J., Zeng, H., Cai, W., Niu, Y., Yang, Z., Shen, Z., and Li, E. (2006) Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma. J. Clin. Pathol. 59, 958-964
93. Hashimoto, Y., Skacel, M., Lavery, I. C., Mukherjee, A. L., Casey, G., and Adams, J. C. (2006) Prognostic significance of fascin expression in advanced colorectal cancer an immunohistochemical study of colorectal adenomas and adenocarcinomas. BMC Cancer 6, 241 (Pubitemid 44687821)
94. Jin, J. S., Yu, C. P., Sun, G. H., Lin, Y. F., Chiang, H., Chao, T. K., Tsai, W. C., and Sheu, L. F. (2006) Increasing expression of fascin in renal cell carcinoma associated with clinicopathological parameters of aggressiveness. Histol. Histopathol. 21, 1287-1293
95. Yoder, B. J., Tso, E., Skacel, M., Pettay, J., Tarr, S., Budd, T., Tubbs, R. R., Adams, J. C., and Hicks, D. G. (2005) The expression of fascin, an actin-bundling motility protein, correlates with hormone receptor-negative breast cancer and a more aggressive clinical course. Clin. Cancer Res. 11, 186-192
96. Pelosi, G., Pastorino, U., Pasini, F., Maissoneuve, P., Fraggetta, F., Iannucci, A., Sonzogni, A., De Manzoni, G., Terzi, A., Durante, E., Bresaola, E., Pezzella, F., and Viale, G. (2003) Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. Br. J. Cancer 88, 537-547
97. Hu, W., McCrea, P. D., Deavers, M., Kavanagh, J. J., Kudelka, A. P., and Verschraegen, C. F. (2000) Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors. Clin. Exp. Metastasis 18, 83-88
98. Dejmek, J. S., and Dejmek, A. (2006) The reactivity to CK5/6 antibody in tumor cells from non-small cell lung cancers shed into pleural effusions predicts survival. Oncol. Rep. 15, 583-587
99. Ernst, M., Najdovska, M., Grail, D., Lundgren-May, T., Buchert, M., Tye, H., Matthews, V. B., Armes, J., Bhathal, P. S., Hughes, N. R., Marcusson, E. G., Karras, J. G., Na, S., Sedgwick, J. D., Hertzog, P. J., and Jenkins, B. J. (2008) STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J. Clin. Investig. 118, 1727-1738
100. Ziober, A. F., Patel, K. R., Alawi, F., Gimotty, P., Weber, R. S., Feldman, M. M., Chalian, A. A., Weinstein, G. S., Hunt, J., and Ziober, B. L. (2006) Identification of a gene signature for rapid screening of oral squamous cell carcinoma. Clin. Cancer Res. 12, 5960-5971
101. Yao, L., Itoh, S., and Furuta, I. (2002) Thymidine phosphorylase expression in oral squamous cell carcinoma. Oral Oncol. 38, 584-590 (Pubitemid 34880119)
102. Ranieri, G., Labriola, A., Achille, G., Florio, G., Zito, A. F., Grammatica, L., and Paradiso, A. (2002) Microvessel density, mast cell density and thymidine phosphorylase expression in oral squamous carcinoma. Int. J. Oncol. 21, 1317-1323
103. Takao, S., Takebayashi, Y., Che, X., Shinchi, H., Natsugoe, S., Miyadera, K., Yamada, Y., Akiyama, S., and Aikou, T. (1998) Expression of thymidine phosphorylase is associated with a poor prognosis in patients with ductal adenocarcinoma of the pancreas. Clin. Cancer Res. 4, 1619-1624
104. Ioachim, E. (2008) Thymidine phosphorylase expression in breast cancer the prognostic significance and its association with other angiogenesis related proteins and extracellular matrix components. Histol. Histopathol. 23, 187-196
105. Chen, L. C., Hsueh, C., Tsang, N. M., Liang, Y., Chang, K. P., Hao, S. P., Yu, J. S., and Chang, Y. S. (2008) Heterogeneous ribonucleoprotein k and thymidine phosphorylase are independent prognostic and therapeutic markers for nasopharyngeal carcinoma. Clin. Cancer Res. 14, 3807-3813
106. Al-Adnani, M. S., Kirrane, J. A., and McGee, J. O. (1975) Inappropriate production of collagen and prolyl hydroxylase by human breast cancer cells in vivo. Br. J. Cancer 31, 653-660
107. Matsul, H., Kubochi, K., Okazaki, I., Yoshino, K., Ishibiki, K., and Kitajima, M. (1999) Collagen biosynthesis in gastric cancer: immunohistochemical analysis of prolyl 4-hydroxylase. J. Surg. Oncol. 70, 239-246
108. Yie, S. M., Yang, H., Ye, S. R., Li, K., Dong, D. D., and Lin, X. M. (2007) Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma. Ann. Surg. Oncol. 14, 2721-2729
109. Ramos, D. M., Chen, B., Regezi, J., Zardi, L., and Pytela, R. (1998) Tenascin-C matrix assembly in oral squamous cell carcinoma. Int. J. Cancer 75, 680-687 (Pubitemid 28145813)
110. Harada, T., Shinohara, M., Nakamura, S., and Oka, M. (1994) An immunohistochemical study of the extracellular matrix in oral squamous cell carcinoma and its association with invasive and metastatic potential. Virchows Arch. 424, 257-266 (Pubitemid 24157883)
111. Yoshikawa, K., Katagata, Y., and Kondo, S. (1998) Biochemical and immunohistochemical analyses of keratin expression in basal cell carcinoma. J. Dermatol. Sci. 17, 15-23
112. Nikitakis, N. G., Rivera, H., Lopes, M. A., Siavash, H., Reynolds, M. A., Ord, R. A., and Sauk, J. J. (2003) Immunohistochemical expression of angiogenesis-related markers in oral squamous cell carcinomas with multiple metastatic lymph nodes. Am. J. Clin. Pathol. 119, 574-586
113. Cao, D., Maitra, A., Saavedra, J. A., Klimstra, D. S., Adsay, N. V., and Hruban, R. H. (2005) Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways. Mod. Pathol. 18, 752-761
114. Maitra, A., Iacobuzio-Donahue, C., Rahman, A., Sohn, T. A., Argani, P., Meyer, R., Yeo, C. J., Cameron, J. L., Goggins, M., Kern, S. E., Ashfaq, R., Hruban, R. H., and Wilentz, R. E. (2002) Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein 47. Am. J. Clin. Pathol. 118, 52-59
115. Yu, E., Lee, K. W., and Lee, H. J. (2000) Expression of promyelocytic leukaemia protein in thyroid neoplasms. Histopathology 37, 302-308 (Pubitemid 30781583)
116. Zheng, H. C., Takahashi, H., Li, X. H., Hara, T., Masuda, S., Guan, Y. F., and Takano, Y. (2008) Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas. Hum. Pathol. 39, 1042-1049
117. Langer, R., Feith, M., Siewert, J. R., Wester, H. J., and Hoefler, H. (2008) Expression and clinical significance of glucose regulated proteins GRP78 (BiP) and GRP94 (GP96) in human adenocarcinomas of the esophagus. SMC Cancer 8, 70
118. Salzman, R., Kanková, K., Pácal, L., Tomandl, J., Horáková, Z., and Kostrica, R. (2007) Increased activity of superoxide dismutase in advanced stages of head and neck squamous cell carcinoma with locoregional metastases. Neoplasma 54, 321-325
119. Hu, H., Luo, M. L., Du, X. L., Feng, Y. B., Zhang, Y., Shen, X. M., Xu, X., Cai, Y., Han, Y. L., and Wang, M. R. (2007) Up-regulated manganese superoxide dismutase expression increases apoptosis resistance in human esophageal squamous cell carcinomas. Chin Med. J. 120, 2092-2098 (Pubitemid 350268156)
120. Ohuchida, K., Mizumoto, K., Miyasaka, Y., Yu, J., Cui, L., Yamaguchi, H., Toma, H., Takahata, S., Sato, N., Nagai, E., Yamaguchi, K., Tsuneyoshi, M., and Tanaka, M. (2007) Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis. J. Pathol. 213, 275-282 (Pubitemid 350074017)
121. Yao, R., Lopez-Beltran, A., Maclennan, G. T., Montironi, R., Eble, J. N., and Cheng, L. (2007) Expression of S100 protein family members in the pathogenesis of bladder tumors. Anticancer Res. 27, 3051-3058 (Pubitemid 47607526)
122. Kyriazanos, I. D., Tachibana, M., Dhar, D. K., Shibakita, M., Ono, T., Kohno, H., and Nagasue, N. (2002) Expression and prognostic significance of S100A2 protein in squamous cell carcinoma of the esophagus. Oncol. Rep. 9, 503-510
123. Shinohara, M., Nakamura, S., Harada, T., Shimada, M., and Oka, M. (1996) Mode of tumor invasion in oral squamous cell carcinoma: improved grading based on immunohistochemical examination of extracellular matrices. Head Neck 18, 153-159 (Pubitemid 26075356)
124. Qi, Y., Chiu, J. F., Wang, L., Kwong, D. L., and He, Q. Y. (2005) Comparative proteomic analysis of esophageal squamous cell carcinoma. Proteomics 5, 2960-2971 (Pubitemid 41059772)
125. Ioachim, E., Charchanti, A., Briasoulis, E., Karavasilis, V., Tsanou, H., Arvanitis, D. L., Agnantis, N. J., and Pavlidis, N. (2002) Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression. Eur. J. Cancer 38, 2362-2370 (Pubitemid 35387487)
126. Warawdekar, U. M., Zingde, S. M., Iyer, K. S., Jagannath, P., Mehta, A. R., and Mehta, N. G. (2006) Elevated levels and fragmented nature of cellular fibronectin in the plasma of gastrointestinal and head and neck cancer patients. Clin. Chim. Acta 372, 83-93
127. Pietruszewska, W., Kobos, J., Bojanowska-Pozniak, K., Durko, M., and Gryczyński, M. (2006) Immunohistochemical analysts of the fibronectin expression and its prognostic value in patients with laryngeal cancer. Otolaryngol. Pol. 60, 697-702
128. Yao, L., Zhao, Y. L., Itoh, S., Wada, S., Yue, L., and Furuta, I. (2000) Thrombospondin-1 expression in oral squamous cell carcinomas: correlations with
129. Hayashido, Y., Nakashima, M., Urabe, K., Yoshioka, H., Yoshioka, Y., Hamana, T., Kitano, H., Koizumi, K., and Okamoto, T. (2003) Role of stromal thrombospondin-1 in motility and proteolytic activity of oral squamous cell carcinoma cells. Int. J. Mol. Med. 12, 447-452
130. Albo, D., and Tuszynski, G. P. (2004) Thrombospondin-1 up-regulates tumor cell invasion through the urokinase plasminogen activator receptor in head and neck cancer cells. J. Surg. Res. 120, 21-26
131. Kodama, J., Hashimoto, I., Seki, N., Hongo, A., Yoshinouchi, M., Okuda, H., and Kudo, T. (2001) Thrombospondin-1 and -2 messenger RNA expression in invasive cervical cancer: correlation with angiogenesis and prognosis. Clin. Cancer Res. 7, 2826-2831
132. Grossfeld, G. D., Carroll, P. R., Lindeman, N., Meng, M., Groshen, S., Feng, A. C., Hawes, D., and Cote, R. J. (2002) Thrombospondin-1 expression in patients with pathologic stage T3 prostate cancer undergoing radical prostatectomy: association with p53 alterations, tumor angiogenesis, and tumor progression. Urology 59, 97-102 (Pubitemid 34059314)
133. Miyanaga, K., Kato, Y., Nakamura, T., Matsumura, M., Amaya, H., Horiuchi, T., Chiba, Y., and Tanaka, K. (2002) Expression and role of thrombospondin-1 in colorectal cancer. Anticancer Res. 22, 3941-3948
134. Albo, D., Shinohara, T., and Tuszynski, G. P. (2002) Up-regulation of matrix metalloproteinase 9 by thrombospondin 1 in gastric cancer. J. Surg. Res. 108, 51-60
135. Chang, J. T., Wang, H. M., Chang, K. W., Chen, W. H., Wen, M. C., Hsu, Y. M., Yung, B. Y., Chen, I. H., Liao, C. T., Hsieh, L. L., and Cheng, A. J. (2005) Identification of differentially expressed genes in oral squamous cell carcinoma (OSCC): overexpression of NPM, CDK1 and NDRG1 and underexpression of CHES1. Int. J. Cancer 114, 942-949
136. Yan, X., Chua, M. S., Sun, H., and So, S. (2008) N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells. Cancer Lett. 262, 133-142
137. Chua, M. S., Sun, H., Cheung, S. T., Mason, V., Higgins, J., Ross, D. T., Fan, S. T., and So, S. (2007) Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. Mod. Pathol. 20, 76-83
138. Wang, Z., Wang, F., Wang, W. Q., Gao, Q., Wei, W. L., Yang, Y., and Wang, G. Y. (2004) Correlation of N-myc downstream-regulated gene 1 overexpression with progressive growth of colorectal neoplasm. World J. Gastroenterol. 10, 550-554
139. Chung, C. H., Parker, J. S., Karaca, G., Wu, J., Funkhouser, W. K., Moore, D., Butterfoss, D., Xiang, D., Zanation, A., Yin, X., Shockley, W. W., Weissler, M. C., Dressier, L. G., Shores, C. G., Yarbrough, W. G., and Perou, C. M. (2004) Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 5, 489-500 (Pubitemid 38610250)
140. Nishimori, T., Tomonaga, T., Matsushita, K., Oh-Ishi, M., Kodera, Y., Maeda, T., Nomura, F., Matsubara, H., Shimada, H., and Ochiai, T. (2006) Proteomic analysis of primary esophageal squamous cell carcinoma reveals downregulation of a cell adhesion protein, periplakin. Proteomics 6, 1011-1018 (Pubitemid 43260225)
141. Yao, R., Davidson, D. D., Lopez-Beltran, A., MacLennan, G. T., Montironi, R., and Cheng, L. (2007) The S100 proteins for screening and prognostic grading of bladder cancer. Histol. Histopathol. 22, 1025-1032
142. Ji, J., Zhao, L., Wang, X., Zhou, C., Ding, F., Su, L., Zhang, C., Mao, X., Wu, M., and Liu, Z. (2004) Differential expression of S100 gene family in human esophageal squamous cell carcinoma. J. Cancer Res. Clin. Oncol. 130, 480-486